These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35500831)

  • 21. Inducible Nitric Oxide Synthase Is a Key Host Factor for
    Bando H; Lee Y; Sakaguchi N; Pradipta A; Ma JS; Tanaka S; Cai Y; Liu J; Shen J; Nishikawa Y; Sasai M; Yamamoto M
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forward genetics screens using macrophages to identify Toxoplasma gondii genes important for resistance to IFN-γ-dependent cell autonomous immunity.
    Walwyn O; Skariah S; Lynch B; Kim N; Ueda Y; Vohora N; Choe J; Mordue DG
    J Vis Exp; 2015 Mar; (97):52556. PubMed ID: 25867017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Armed and dangerous: Toxoplasma gondii uses an arsenal of secretory proteins to infect host cells.
    Carruthers VB
    Parasitol Int; 1999 Mar; 48(1):1-10. PubMed ID: 11269320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxoplasma gondii-Induced Neutrophil Extracellular Traps Amplify the Innate and Adaptive Response.
    Miranda FJB; Rocha BC; Pereira MCA; Pereira LMN; de Souza EHM; Marino AP; Costa PAC; Vasconcelos-Santos DV; Antonelli LRV; Gazzinelli RT
    mBio; 2021 Oct; 12(5):e0130721. PubMed ID: 34607465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma.
    Nishikawa Y; Xuenan X; Makala L; Vielemeyer O; Joiner KA; Nagasawa H
    Int J Parasitol; 2003 Nov; 33(13):1525-35. PubMed ID: 14572515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxoplasma gondii ROP18
    Chen M; Yao L; Zhou L; Yang P; Zou W; Xu L; Li S; Peng H
    FASEB J; 2022 Feb; 36(2):e22171. PubMed ID: 35084749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apical Organelle Secretion by Toxoplasma Controls Innate and Adaptive Immunity and Mediates Long-Term Protection.
    Sloves PJ; Mouveaux T; Ait-Yahia S; Vorng H; Everaere L; Sangare LO; Tsicopoulos A; Tomavo S
    J Infect Dis; 2015 Nov; 212(9):1449-58. PubMed ID: 25910629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Host immune responses to Toxoplasma gondii.
    Sasai M; Pradipta A; Yamamoto M
    Int Immunol; 2018 Mar; 30(3):113-119. PubMed ID: 29408976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic Control of IFN-γ Host Responses During Infection With
    Nast R; Choepak T; Lüder CGK
    Front Immunol; 2020; 11():581241. PubMed ID: 33072127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Engineered Expression of Mitochondrial Association Factor 1b on
    English ED; Boyle JP
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity.
    Fox BA; Sanders KL; Rommereim LM; Guevara RB; Bzik DJ
    PLoS Genet; 2016 Jul; 12(7):e1006189. PubMed ID: 27447180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling of myristoylation in
    Broncel M; Dominicus C; Vigetti L; Nofal SD; Bartlett EJ; Touquet B; Hunt A; Wallbank BA; Federico S; Matthews S; Young JC; Tate EW; Tardieux I; Treeck M
    Elife; 2020 Jul; 9():. PubMed ID: 32618271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Rhoptry Pseudokinase ROP54 Modulates Toxoplasma gondii Virulence and Host GBP2 Loading.
    Kim EW; Nadipuram SM; Tetlow AL; Barshop WD; Liu PT; Wohlschlegel JA; Bradley PJ
    mSphere; 2016; 1(2):. PubMed ID: 27303719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphotoxin β Receptor: a Crucial Role in Innate and Adaptive Immune Responses against Toxoplasma gondii.
    Tersteegen A; Sorg UR; Virgen-Slane R; Helle M; Petzsch P; Dunay IR; Köhrer K; Degrandi D; Ware CF; Pfeffer K
    Infect Immun; 2021 May; 89(6):. PubMed ID: 33753412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.
    Denkers EY
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):193-203. PubMed ID: 14642303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immunity-related GTPases.
    Takács AC; Swierzy IJ; Lüder CG
    PLoS One; 2012; 7(9):e45440. PubMed ID: 23024821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cluster of interferon-γ-inducible p65 GTPases plays a critical role in host defense against Toxoplasma gondii.
    Yamamoto M; Okuyama M; Ma JS; Kimura T; Kamiyama N; Saiga H; Ohshima J; Sasai M; Kayama H; Okamoto T; Huang DC; Soldati-Favre D; Horie K; Takeda J; Takeda K
    Immunity; 2012 Aug; 37(2):302-13. PubMed ID: 22795875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RabGDIα is a negative regulator of interferon-γ-inducible GTPase-dependent cell-autonomous immunity to Toxoplasma gondii.
    Ohshima J; Sasai M; Liu J; Yamashita K; Ma JS; Lee Y; Bando H; Howard JC; Ebisu S; Hayashi M; Takeda K; Standley DM; Frickel EM; Yamamoto M
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):E4581-90. PubMed ID: 26240314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strain- and Dose-Dependent Reduction of
    Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
    Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
    [No Abstract]   [Full Text] [Related]  

  • 40. IFN-induced cell-autonomous immune mechanisms in the control of intracellular protozoa.
    Skariah S; Sultan AA; Mordue DG
    Parasitol Res; 2022 Jun; 121(6):1559-1571. PubMed ID: 35435512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.